Method for treating glaucoma with topical or systemic ACE inhibi

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424200, 424220, 424274, A61K 3700, A61K 31675, A61K 3166, A61K 3140

Patent

active

044420897

ABSTRACT:
A method is provided for treating glaucoma by topical or systemic administration of an ACE inhibitor such as captopril.

REFERENCES:
patent: 3711602 (1973-01-01), Herschler
patent: 3873618 (1975-03-01), Smith
patent: 4105776 (1978-08-01), Ondetti et al.
patent: 4127674 (1978-11-01), Leopold
patent: 4132847 (1979-01-01), Kuhla et al.
patent: 4149007 (1979-04-01), Buckler et al.
patent: 4152450 (1979-05-01), Day et al.
patent: 4152451 (1979-05-01), Archer et al.
patent: 4156010 (1979-05-01), Hirschmann
patent: 4168267 (1979-09-01), Petrillo
patent: 4179517 (1979-12-01), Mechoulam et al.
patent: 4197301 (1980-04-01), Smith et al.
Klin. Mbl. Augenheilk, 162 (1973), 637-642.
Biol. Abstr. vol. 71, 34826.
Biol. Abstr. vol. 72, 35289.
Biol. Abstr. vol. 71, 47987.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for treating glaucoma with topical or systemic ACE inhibi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treating glaucoma with topical or systemic ACE inhibi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating glaucoma with topical or systemic ACE inhibi will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-892414

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.